Vogt-Koyanagi-Harada Disease
Symptoms, Doctors, Treatments, Advances & More

Vogt-Koyanagi-Harada Disease Overview

Save information for later
Sign Up

Learn About Vogt-Koyanagi-Harada Disease

What is the definition of Vogt-Koyanagi-Harada Disease?
Vogt-Koyanagi-Harada disease (VKH disease) affects the eyes, ears, nervous system, and skin. The symptoms of VKH occur in different phases. The early symptoms include headaches, eye pain, and dizziness. These are followed by hearing loss and inflammation of the eye (panuveitis). Later symptoms include development of white patches of skin and hair (vitiligo), hair loss (alopecia), cataracts, and glaucoma. The exact cause of VKH disease is unknown, but the symptoms are thought to be due to an abnormal response of the immune system to a viral infection. Genetic factors may be involved. Diagnosis of VKH disease is based on the symptoms, clinical exam, and imaging studies. Other more common diseases may need to excluded before a diagnosis of VKH disease is made.
What are the alternative names for Vogt-Koyanagi-Harada Disease?
  • Vogt-Koyanagi-Harada disease
  • Uveomenigitic syndrome
  • VKH disease
  • VKH syndrome
  • Vogt-Koyanagi-Harada syndrome
Who are the top Vogt-Koyanagi-Harada Disease Local Doctors?
Elite in Vogt-Koyanagi-Harada Disease
Ahmed M. Asrar-Abu El
Elite in Vogt-Koyanagi-Harada Disease
Ahmed M. Asrar-Abu El
Referral may be required
Old Airport Road, 
Riyadh, SA 

Ahmed Asrar-Abu El practices practicing medicine in Riyadh, Saudi Arabia. Mr. Asrar-Abu El is rated as an Elite expert by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Vogt-Koyanagi-Harada Disease, Diabetic Retinopathy, Uveitis, Vitrectomy, and Cataract Removal.

Elite in Vogt-Koyanagi-Harada Disease
Joyce H. Yamamoto
Elite in Vogt-Koyanagi-Harada Disease
Joyce H. Yamamoto
Referral may be required
Sao Paulo, SP, BR 

Joyce Yamamoto practices practicing medicine in Sao Paulo, Brazil. Ms. Yamamoto is rated as an Elite expert by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Vogt-Koyanagi-Harada Disease, Uveitis, Endophthalmitis, Vitrectomy, and Cataract Removal.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Vogt-Koyanagi-Harada Disease
Viviane M. Sakata
Elite in Vogt-Koyanagi-Harada Disease
Viviane M. Sakata
Referral may be required
Sao Paulo, SP, BR 

Viviane Sakata practices practicing medicine in Sao Paulo, Brazil. Ms. Sakata is rated as an Elite expert by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Vogt-Koyanagi-Harada Disease, Uveitis, and Retinal Detachment.

View All Doctors
What are the latest Vogt-Koyanagi-Harada Disease Clinical Trials?
Influência de imunomodulação Precoce Influence of Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease: a Prospective Study
Influência de imunomodulação Precoce Influence of Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease: a Prospective Study
Enrollment Status: Recruiting
Publish Date: May 07, 2026
Intervention Type: Drug
Study Phase: Not Applicable

Summary: This prospective study will include patients with Vogt-Koyanagi-Harada disease from disease onset, treated with early systemic high-dose corticosteroid and immunosuppressive therapy. Clinical and subclinical signs of disease activity added with electroretinogram exams, through predefined intervals, will be evaluated through a minimum 12-month follow-up.

Match to trials
Find the right clinical trials for you in under a minute
Get started
An Observational Study of Adalimumab in the Treatment of Acute Vogt-Koyanagi-Harada Disease
An Observational Study of Adalimumab in the Treatment of Acute Vogt-Koyanagi-Harada Disease
Enrollment Status: Recruiting
Publish Date: July 03, 2024
Intervention Type: Drug

Summary: This project is designed to test the hypothesis that adalimumab is clinically useful for patients with acuta Vogt-Koyanagi-Harada disease

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center